BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9235424)

  • 1. [The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension].
    Mayoral E; Lapetra J; Santos JM; López A; Ruiz J; Cayuela A
    Med Clin (Barc); 1997 Apr; 108(13):485-9. PubMed ID: 9235424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White coat effect and white coat hypertension in pediatric patients.
    Matsuoka S; Kawamura K; Honda M; Awazu M
    Pediatr Nephrol; 2002 Nov; 17(11):950-3. PubMed ID: 12432440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M; Ruxer J; Barański M; Roszczyk N; Markuszewski L
    Ann Acad Med Stetin; 2008; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home blood pressure measurement in prehypertension and untreated hypertension: comparison with ambulatory blood pressure monitoring and office blood pressure.
    Zhuo S; Wen W; Li-Yuan M; Shu-Yu W; Yi-Xin W
    Blood Press Monit; 2009 Dec; 14(6):245-50. PubMed ID: 19918171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical correlates of white coat hypertension in chronic kidney disease.
    Minutolo R; Borrelli S; Scigliano R; Bellizzi V; Chiodini P; Cianciaruso B; Nappi F; Zamboli P; Conte G; De Nicola L
    Nephrol Dial Transplant; 2007 Aug; 22(8):2217-23. PubMed ID: 17420167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T; Horio T; Tomiyama M; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics of the white coat hypertension].
    Vinyoles E; de la Figuera M
    Med Clin (Barc); 1995 Sep; 105(8):287-91. PubMed ID: 7475478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the white-coat effect at multiple visits before and during treatment.
    Verberk WJ; Kroon AA; Thien T; Lenders JW; van Montfrans GA; Smit AJ; de Leeuw PW
    J Hypertens; 2006 Dec; 24(12):2357-63. PubMed ID: 17082716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the white-coat phenomenon in patients with primary hypertension.
    Zhu N; Bu M; Chen D; Li T; Qian J; Yu Q; Chen Q; Wan C; Qu H; Zhu M; Zou X
    Hypertens Res; 2008 Jan; 31(1):37-41. PubMed ID: 18360016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of subjects with white-coat hypertension and persistently normal ambulatory blood pressure.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Sacchi N; Guerrieri M; Comparato E; Porcellati C
    Blood Press Monit; 1996 Jun; 1(3):217-222. PubMed ID: 10226230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White coat hypertension in adolescents.
    Koch VH; Furusawa EA; Saito MI; Colli A; Ignes EC; Okay Y; Mion Júnior D
    Clin Nephrol; 1999 Nov; 52(5):297-303. PubMed ID: 10584993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines.
    Addison C; Varney S; Coats A
    J Hum Hypertens; 2001 Aug; 15(8):535-8. PubMed ID: 11494091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK; Bagatin J; Kokić S; Ostojić SB; Carević V; Berović N
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Day-night differences of arterial pressure in "white coat" arterial hypertension].
    Mora-Maciá J; Ocón Pujadas J; Díaz Gómez JM; del Río Pérez G
    Rev Clin Esp; 1993 Jan; 192(1):11-5. PubMed ID: 8465023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.